Artificial Intelligence as a Decision Making Tool in Neurology
Launched by RAMBAM HEALTH CARE CAMPUS · Mar 27, 2025
Trial Information
Current as of May 09, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how an artificial intelligence (AI) tool can help doctors make better decisions when treating patients with neurological conditions, especially in regions where English is not the primary language. The goal is to see if using this AI system can improve the way doctors diagnose and treat patients by analyzing data and understanding natural language, which means how we normally talk and write. The researchers believe that this technology could make patient care faster and more accurate.
To participate in the trial, individuals must be between the ages of 65 and 75 and be able to give informed consent, meaning they can understand and agree to take part in the study. Unfortunately, if someone cannot provide informed consent, they will not be eligible. Participants will have the opportunity to be part of a cutting-edge research effort that aims to enhance the quality of care for patients with neurological issues. It's important to know that the trial is currently active but not recruiting new participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consent
- Exclusion Criteria:
- • Unable to give informed consent
About Rambam Health Care Campus
Rambam Health Care Campus is a leading medical institution located in Haifa, Israel, renowned for its comprehensive patient care, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, Rambam is dedicated to advancing healthcare through innovative research and development, facilitating a wide range of clinical studies across various therapeutic areas. The campus boasts state-of-the-art facilities, a multidisciplinary team of expert researchers and clinicians, and a robust infrastructure that supports rigorous scientific inquiry and ethical standards in clinical trials. By fostering collaboration and leveraging cutting-edge technology, Rambam Health Care Campus aims to enhance treatment options and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Haifa, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported